Drugs companies putting profit ahead of medical discoveries, warn scientists

Researchers say companies spend vastly more on marketing than on new treatments

The multi-billion pound pharmaceutical industry has spent the last decade developing new drugs which have produced little benefit and caused considerable harm, experts say today.

Click HERE to view graphic

The claim that there is an "innovation crisis" in pharmaceuticals because of the difficulty and expense of discovering new drugs is a myth fostered by an industry whose chief focus is on marketing, they add.

Counter to drug industry claims that the pipeline of new drugs is running dry, the number of new drugs being licensed each year has remained at between 15 and 25. But most involve minor tweaks to existing drugs, designed to grab a slice of an existing market rather than offering genuine therapeutic innovation.

Independent reviews suggest that 85 to 90 per cent provide little benefit over existing treatments with some, such as Vioxx the painkiller and Avandia, the diabetes drug, causing serious side effects which led to their withdrawal, the latter's in Europe.

Writing in the British Medical Journal, Professor Donald Light from the University of Medicine of New Jersey and Joel Lexchin from York University in Toronto say the situation has remained the same for 50 years. The incentives for drug development are wrong and have skewed the behaviour of the industry.

"This is the real innovation crisis: pharmaceutical research and development turns out mostly minor variations on existing drugs and most new drugs are not superior on clinical measures. [They] have also produced an epidemic of serious adverse reactions that have added to national healthcare costs," they say.

More is spent on marketing (25 per cent of revenues) than on discovering new molecules (1.3 per cent). Drug industry claims that the cost of bringing a new drug to market is £1bn and is unsustainable are exaggerated, they claim. Research and development costs did rise substantially between 1995 and 2010 by $34.2bn (£21.9bn), they concluded, but revenues increased six times faster – by $200.4bn.

Companies avoid mentioning this "extraordinary revenue return", they said, adding that up to 80 per cent of drug spending is used by the industry on promotion. The authors call for licensing authorities around the world to stop approving new drugs of little therapeutic value. They suggest large cash prizes should be awarded for genuinely new therapeutic agents in lieu of patent protection.

The European Medicines Agency, which licenses drugs in the UK and Europe, keeps certain data about their safety and efficacy secret. Yet 29 per cent of new biological agents approved by the EMA received safety warnings within the first 10 years.

In a second paper, researchers from the London School of Economics in the UK argue that drug manufacturers should be made to demonstrate that their products are superior to existing treatments before being granted a licence, rather than, as now, superior only to a placebo.

"Changing the nature of regulation could encourage manufacturers to concentrate on the development of new drugs in therapeutic areas with few alternatives," they say. "Supplementing regulation with scientific advice and guidance can steer manufacturer's interest and efforts into key research priorities."

Stephen Whitehead, chief executive of the Association of the British Pharmaceutical Industry, said: "We strongly disagree with the claims made in these papers. Medical research has always rested on iterative and gradual innovation rather than breakthrough advances which are very rare. If it were not for the incremental improvements made in the treatment of HIV, the disease would still be terminal rather than a manageable condition."

Independent Comment
blog comments powered by Disqus
News in pictures
World news in pictures
Life & Style blogs

Where do most millionaires live in the UK?

Plus lateral thinking and living on London's waterways

Wandsworth tops aspiring young professionals hotspot list

Other popular areas include Didsbury, Clifton in Bristol, central Cambridge and West Bridgford

Christian GPs and the morning after pill: Much needed clarification

Doctors are allowed to have personal beliefs, just as long as these beliefs do not interfere with th...

       

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    Day In a Page

    Watch out Watford: Here comes the secretive Bilderberg Group

    Watch out Watford: Here comes the secretive Bilderberg Group

    A meeting of global power brokers in a Hertfordshire hotel is exciting conspiracy theorists, but what are they really about?
    'The ultimate all-in-one home entertainment system': Microsoft finally unveils its Xbox ONE console

    'The ultimate all-in-one home entertainment system'

    Microsoft finally unveils its Xbox ONE console
    Plenty of Fish dating site founder pulls 'Intimate Encounters' option to ward off sleazy men

    Plenty of sleaze

    Dating website pulls intimate 'hook-up' section to curb harassment
    Inferno author Dan Brown 'honoured' to be invited to join the Freemasons

    The Freemasons’ Code

    Dan Brown reveals the message that told him door to the lodge is open
    Not secure any more: G4S boss heads for exit at last

    Not secure any more: G4S boss heads for exit at last

    Nick Buckles survived the Olympics débâcle and a £5bn bid fiasco but a profit warning finally triggered his downfall
    How to say ‘I’m a sellout’: Tumblr’s David Karp’s message of reassurance to his staff sounded very familiar

    How to say ‘I’m a sellout’

    Tumblr’s David Karp’s message of reassurance to his staff sounded very familiar
    Why clubs are keen to take a stand

    Why clubs are keen to take a stand

    There's a real desire around the grounds for safe standing. But will the authorities listen?
    In the end the fans decided Tony Pulis had made a pig's ear of the job at Stoke City

    In the end the fans decided Tony Pulis had made a pig's ear of the job at Stoke City

    Disillusion with a siege mentality and negative playing style made change inevitable
    James Lawton: The James Hunt I knew is the subject of a new F1 movie

    James Lawton: The James Hunt I knew is the subject of a new F1 movie

    British driver was fascinating man whose epic duel with Niki Lauda in 1976 was typical of an era of glamour and glory – but also the ever-present threat of death
    Stuart Hogg: Ready to climb his own Everest

    Stuart Hogg: Ready to climb his own Everest

    Lions' cub, 20, joins long line of players from Scottish borders club Hawick given opportunity to make his mark at highest level
    Carl Froch handed rare chance of revenge with dream rematch

    Steve Bunce on Boxing

    Carl Froch handed rare chance of revenge with dream rematch against Mikel Kessler
    'There is a battle going on inside us that is never discussed'

    Masculinity in crisis?

    'There is a battle going on inside us that is never discussed'
    Have US shock jocks gone too far?

    Have US shock jocks gone too far?

    An incendiary remark from Rush Limbaugh may be the beginning of the end for outspoken right-wing US broadcasters
    The ‘Beverly Hills’ of Surrey pays more income tax than big cities of the North

    The ‘Beverly Hills’ of Surrey

    Elmbridge pays more income tax than big cities of the North
    Heavenly Bodies

    Heavenly Bodies

    Michael Landy's artistic marriage made in heaven... and hell